KDM6A and colorectal carcinoma: Remarkably, KDM6A and KMD6B inhibition greatly decreased the expression of bulk and LGR5-refined ISC signatures (Figure 4E), which have been shown to be able to identify CSCs in CRC and predict CRC recurrence.